N.M. McKeown, J.B. Blumberg and C-Y.O. Chen. USDA at
Tufts Univ.
3:30
125.3
Tissue distribution of nobiletin and its
metabolites in mice after oral administration of nobiletin.
M.
Wang, J. Zheng, Z. Zhong, M. Song and X. Wu. Univ. of
Massachusetts Amherst.
3:45
125.4
Relationship between in vitro absorption of
chondroitin sulfate (cs) and its molecular weight.
L. Surapaneni,
V. Haley-Zitlin, A. Bodine, X. Jiang and J. Brooks. Clemson
Univ. and Pharmavite LLC, Northridge, CA.
4:00
125.5
Fatty acid bioavailability study of single oral
doses of milled chia seed snack clusters or chia seed oil in
healthy subjects.
D.C. Nieman, N.D. Gillitt, A.M. Knab, L.
Cialdella-Kam and F. Jin. Appalachian State Univ. and Dole
Nutr. Res. Lab., Kannapolis.
SUNDAY NUTRITION
36
4:15
125.6
Absorption, distribution, metabolism and
elimination of a stable isotope-labelled anthocyanin in humans.
C.D. Kay, N.P. Botting, A. Cassidy, C. Czank, R. de Ferrars,
P.A. Kroon, D.J. Morrison, T. Preston and Q. Zang. Univ. of
East Anglia, Univ. of St Andrews, Inst. of Food Res., Norwich
and Univ. of Glasgow, U.K.
4:30
125.7
The metabolic fate of anthocyanins in humans.
R.M. de Ferrars, A. Cassidy, P. Curtis, K. Saki Raheem, Q.
Zhang and C.D. Kay. Univ. of East Anglia and St Andrews
Univ., U.K.
4:45
125.8
High amylose and stearic acid-modified
resistant starch: human post-prandial gut fermentation and
blood glucose response.
E. Haugabrooks, Y. Ai, J-l. Jane and
S. Hendrich. Iowa State Univ.
126. OBESITY: CARBOHYDRATE INTAKE AND
WEIGHT MANAGEMENT
Minisymposium
(Sponsored by: Obesity RIS)
s
un
. 3:00
pm
—B
oston
C
onvention
& e
xhiBition
C
enter
, 156B
C
haired
: F. G
reenWay
C
oChaired
: y. C
hu
3:00
126.1
Sugar-sweetened beverage consumption is
associated with relative distribution of abdominal adipose tissue
in the Framingham Heart Study.
J. Ma, M. Sloan, C.S. Fox, U.
Hoffmann, P.F. Jacques and N.M. McKeown. USDA at Tufts
Univ., Univ. of Massachusetts Med. Sch., NHLBI, Framington
Heart Study, Harvard Med. Sch. and Massachusetts Gen.
Hosp.
3:15
126.2
Liquid and solid sources of added sugar and
their associations with body weight and metabolic syndrome
components in children.
J. Wang, K. Light, L. Johnson-
Down, D. St-Arnaud-McKenzie, J. O’Loughlin, G. Paradis
and K. Gray-Donald. McGill Univ., Ste. Anne de Bellevue and
Montreal and Univ. of Montreal.
3:30
126.3
Drinking water to dilute urine osmolality is
associated with greater weight loss in pre-adolescents eating
lower glycemic foods.
J.J.D. Stookey, R. Del Toro, J. Hamer,
A. Medina, J. King, A. Higa and V. Ng. Children’s Hosp. & Res.
Ctr. Oakland.
3:45
126.4
Effect of two oat-based breakfast cereals on
appetite, satiety, and food intake.
C.J. Rebello, W. Johnson, C.
Martin, N. Bordenave, B.J.W. van Klinken, M. O’Shea, Y. Chu
and F. Greenway. Pennington Biomed. Res. Ctr., Baton Rouge
and PepsiCo Inc. Barrington, IL.
4:00
126.5
Predicting satiety responses of cereals in vitro:
oatmeal shows gastric gelling behavior.
B.J-W. van Klinken,
Y. Chu, N. Bordenave, C. Vink, S. de Jong, R. Ruijschop, T.
Lambers and M. O’Shea. PepsiCo, Barrington, IL and Nizo
Foods, Ede, Netherlands.
4:15
126.6
Association of whole grain intake and
longitudinal changes in abdominal adiposity in the Framingham
Heart Study.
H. Wang, P. Quatromoni, C.S. Fox, P.F. Jacques
and N.M. McKeown. USDA at Tufts Univ., Boston Univ.,
NHLBI’s Framingham Heart Study, Brigham and Women’s
Hosp. and Friedman Sch. of Nutr. Sci. and Policy, Tufts Univ.
4:30
126.7
Determination of the glycemic index of a weight
loss meal plan program using energy controlled, pre-packaged
products.
M. Nichols, A.M. Jenkins, A.N. Fabricatore, V.
Vuksan, T.M.S. Wolever and B.P. Daggy. Nutrisystem Inc.,
Fort Washington, PA and Glycemic Index Labs. Inc., Toronto.
4:45
126.8
Sodium alginate addition to chocolate milk
reduces appetite and glycemic responses in healthy young
men.
D. El Khoury , H.D. Goff, S. Berengut, N. Yavorska,
R. Kubant and G.H. Anderson. Univ. of Toronto and Univ. of
Guelph.
127. POLYUNSATURATED FATTY ACIDS AND
HEALTH
Minisymposium
(Sponsored by: Energy and Macronutrient Metabolism RIS)
s
un
. 3:00
pm
—B
oston
C
onvention
& e
xhiBition
C
enter
, 156C
C
haired
: D.B. J
ump
C
oChaired
: s.r. s
haiKh
3:00
127.1
Perinatal and post-weaning diets high in
omega-3 fatty acids upregulate genes involved in neurotrophin
signaling.
K.A. Balogun and S.K. Cheema. Mem. Univ. of
Newfoundland.
3:15
127.2
Maternal n-3 fatty acid supplementation before
and during pregnancy provides neuroprotection after neonatal
hypoxic-ischemic brain injury.
C. Fan, K. Mayurasakorn, V.S.
Ten, K. Qi and R.J. Deckelbaum. Columbia Univ. Med. Ctr.,
Beijing Children’s Hosp., Capital Med. Univ.
3:30
127.3
Race, pregravid BMI and gestational weight
gain determine placental fatty acid transfer.
A.R. Smither,
H.A. Durham, S. Buzhardt, F.A. Moore, W.T. Cefalu and C.J.
Lammi-Keefe. LSU, Pennington Biomed. Res. Ctr., Woman’s
Hosp. and LSU AgCtr., Baton Rouge.
3:45
127.4
The Sydney Diet Heart Study: a randomised
controlled trial of linoleic acid for secondary prevention of
coronary heart disease and death.
C.E. Ramsden, D. Zamora,
K. Faurot, S. Majchrzak and J. Hibbeln. NIAAA, NIH and
Univ. of North Carolina at Chapel Hill.
4:00
127.5
Differential effect of docosahexaenoic acid
versus myrisitc acid on inflammatory cytokines.
K.L. Honda,
N.R. Matthan, S. Lamon-Fava, D. Wu and A.H. Lichtenstein.
USDA at Tufts Univ.
4:15
127.6
EPA promotes fatty acid storage and
thermogenic capacity in primary differentiated mouse
subcutaneous adipocytes.
M. Zhao and X. Chen. Univ. of
Minnesota-Twin Cities, St. Paul.
4:30
127.7
Effects of modifying both the linoleic and
linolenic acid content of a 45% kcal DIO diet on body weight
and metabolic parameters in C57BL6J mice.
R.E. Ward, A.
Zhou, M. Lefevre and K. Hintze. Utah State Univ.
4:45
127.8
Establishing and maintaining the complex
adhesions of the testes: a role for the omega-3 DHA.
T.L.
Abbott, R.A. Hess, M. Sivaguru and M.T. Nakamura. Univ. of
Illinois, Urbana.
NUTRITION SUNDAY
37
S
U
N
Pathology
130. MOLECULAR AND CELLULAR BASIS OF
DISEASE: STEM CELLS, NEOPLASIA,
DEVELOPMENT, WOUND HEALING (PART 1)
Symposium
s
un
. 8:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
, 160B
C
haired
: p. s
hepherD
anD
C.a. W
iley
Stem Cells
Neoplasia
8:30
P13 kinase signaling and cancer.
P. Shepherd. Univ. of
Auckland.
9:15
Neural stem cell control by Hedgehog and Notch
signaling.
A. Gulino. Sapienza Univ. of Rome.
10:10
Wnt signaling in GI development and tumorigenesis.
R.
Shivdasani. Dana Farber Cancer Inst.
10:45 Beta-catenin in liver development/liver tumors.
S. P.S.
Monga. Univ. of Pittsburgh.
131. MUCOSAL MICROBIAL INTERACTIONS
Minisymposium
s
un
. 8:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
, 160a
C
haired
: B. m
C
C
ormiCK
C
oChaired
: r. J
ones
Epithelial Pathobiology
8:30
131.1
Gut microbiota biofilm disruptions by Giardia:
pathology in human enterocytes and germ-free mice.
J. Beatty,
S. Akierman, K. Rioux, P. Beck, W. McKnight, T. Feener, J.
Wallace and A. Buret. Univ. of Calgary and McMaster Univ.,
Canada.
8:45
131.2
Transepithelial movement of intestinal
pathogens is limited by
gd IEL occludin-dependent migration.
K.L. Edelblum, G. Singh, R. McLeod and J.R. Turner. Univ. of
Chicago.
9:00
131.3
Microbiota-dependent Th17 and Foxp3
+
regulatory T cell differentiation in the intestinal lamina propria.
D. Geem, O. Medina-Contreras, R. Newberry and T.L.
Denning. Emory Univ. and Washington Univ. Sch. of Med.
9:15
131.4
Symbiotic lactobacilli stimulate metazoan gut
proliferation via induction of reactive oxygen species by Nox1.
R. Jones, A. Alam, L. Luo, C.S. Ardita and A.S. Neish. Emory
Univ. Sch. of Med.
9:30
131.5
Regional Wnt signatures in the colon and the
influence of commensal bacteria.
P.A. Neumann, S. Koch, R.
Hilgarth, E. Perez-Chanona, C. Jobin, C.A. Parkos and A.
Nusrat. Emory Univ. Sch. of Med., German Cancer Res. Ctr.
Heidelberg and Univ. of North Carolina at Chapel Hill.
9:45
131.6
Salmonella typhimurium directs the localization
of the desmosomal protein, PERP, to induce inflammation.
K.
Hallstrom, J.E. Casanova and B.A. McCormick. Univ. of
Massachusetts Med. Sch. and Univ. of Virginia Hlth. Syst.
10:00
131.7
Fundamental role for HIF-1
a in expression
of enteric human
b defensin-1. C.J. Kelly, L.E. Glover, E.L.
Campbell, S.F. Ehrentraut, D.J. Kominsky, B.E. Bowers, A.J.
Bayless, B.J. Saeedi and S.P. Colgan. Univ. of Colorado Sch.
of Med.
128. CAREER DEVELOPMENT WORKSHOP AND
BREAKFAST: NON-TRADITIONAL CAREER
OPPORTUNITIES IN PATHOLOGY
Workshop
(Sponsored by: ASIP Committee for Career
Development, Women & Minorities, the Intersociety
Council for Pathology Information and FASEB MARC
(Maximizing Access to Research Careers) Office)
s
un
. 7:00
am
—W
estin
B
oston
W
aterFront
h
otel
,
h
arBor
B
allroom
i
C
haired
: C. K
olarCiK
anD
G. p
asternaCK
Career Development
Graduate students and postdoctoral fellows are often
exposed to only a limited range of career options. All are familiar
with academic careers that range from tenure-track faculty
slots to temporary research positions. Many are also aware of
increasingly scarce teaching positions in liberal arts colleges, and
some may aspire to bench research positions in pharmaceutical
and biotech companies, which are highly competitive. Few,
however, realize that PhD scientists can play major roles in non-
bench positions in industry, both as independent consultants or
as employees of contract research organizations, pharmaceutical
companies, biotech companies, or other organizations. The
speakers will outline their important, rewarding, and well-paid
roles in industry in running clinical trials, educating medical and
scientific professionals, and helping to guide new therapeutics
through the drug approval process in the U.S. and other countries.
7:00 Introduction.
7:10
Implementing clinical trials as a clinical research
associate (CRA).
M. Gentile. Independent Consultant.
7:30
Teaching therapeutic science as a medical science
liaison (MSL).
U. Atif. Shire.
7:50
Toxicologic pathologists in biopharmaceutical discovery
and development.
J. Fikes. AstraZeneca.
8:10
Panel discussion.
129. EXTRACELLULAR VESICLES, MIRNA AND
VASCULAR CELL COMMUNICATION
Symposium
s
un
. 8:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
, 162a
C
haired
: x. B
reaKeFielD
C
oChaired
: F.W. l
usCinsKas
Vascular Biology
8:30
Tumor extracellular vesicles as saboteurs, biomarkers
and therapeutic agents.
X. Breakefield.
Massachusetts Gen. Hosp.
9:15
Exosomes mediate the therapeutic effects of endothelial
progenitor cells for ischemic tissue repair.
D. Lorsodo.
Northwestern Univ., Chicago.
10:00 Immunoregulatory exosomes: novel therapeutics for
treating autoimmune and nflammatory diseases.
P.
Robbins. Univ. of Pittsburgh and Scripps Res. Inst.
10:45 Tissue factor, microparticles and thrombosis.
N.
Mackman. Univ. of North Carolina at Chapel Hill.
SUNDAY PATHOLOGY
38
10:15
131.8
Cleavage of interleukin-8 and attenuation of
neutrophil chemotaxis by a Giardia cathepsin B.
J. Cotton, A.
Bhargava, J. Ferraz, M. Hollenberg, P. Beck and A. Buret.
Univ. of Calgary, Canada.
10:30
131.9
The role of shiga toxin in promoting
transepithelial migration of neutrophils.
E.J. Boll, R. Szabady,
D. Jandhyala, C. Thorpe and B. McCormick. Univ. of
Massachusetts Med. Sch. and Tufts Med. Ctr.
10:45
131.10 Human airway secretions inhibit Pseudomonas
aeruginosa activity: effects on survival, growth, and flagellar
motility.
A.K. Weitz, J.L. Willborg, S.M. Hinz and J.L. Bankers-
Fulbright. Augsburg Col., MN.
11:00
131.11 Commensal Lactobacillus modulate ROS-
dependent cytoprotective gene expression in intestinal
epithelia.
C.S. Ardita, R.M. Jones, J.W. Mercante, L. Luo, C.
Gates, K.H. Moberg and A.S. Neish. Emory Univ.
11:15
131.12 Colonic MUC2 mucin regulates the expression
and antimicrobial activity of
b-defensin 2. E.R. Cobo, V.
Kissoon-Singh, E. Trusevych, F. Moreau and K. Chadee.
Univ. of Calgary, Canada.
132. CELL MATRIX ADHESION AND WOUND REPAIR
Minisymposium
s
un
. 8:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
, 160C
C
haired
: n. l
ouis
C
oChaired
: a. i
vanov
8:30
132.1
The effect of adiponectin on intestinal
fibroblasts.
C.M. Williams, R. Fayad, M.K. Anderson and
T.A. Reaves. Med. Univ. of South Carolina and Univ. of South
Carolina.
8:45
132.2
CCN1/Cyr61 regulates sonic hedgehog
signaling through activation of Notch-1 in pancreatic
carcinogenesis: a novel targeting pathway for pancreatic
cancer therapy.
I. Haque, A. De, M. Majumder, S. Mehta, D.
McGregor, S.K. Banerjee, P.V. Veldhuizen and S. Banerjee.
Univ. of Kansas Med. Ctr. and Kansas City VA Med. Ctr.
9:00
132.3
Epithelial wound repair: insights into the
multifaceted roles of annexin A1.
G. Leoni, P-A. Neumann,
A. Alam, R.S. Hilgarth, D.J. Lambeth, D. Kusters, C.
Reutelingsperger, M. Perretti, C.A. Parkos, A.S. Neish
and A. Nusrat. Emory Univ., CARIM Sch. for Cardiovas. Dis.,
Maastricht and William Harvey Res. Inst., London, U.K.
9:15
132.4
An extracellular matrix-based mechanism of
rapid neutrophil extracellular trap formation in response to
C. albicans.
A.S. Byrd, X.M. O’Brien, C.M. Johnson, L.M.
Lavigne and J.S. Reichner. Rhode Island Hosp. and Warren
Alpert Med. Sch. and Grad. Prog. in Pathobiol.
9:30
132.5
aSNAP controls b1-integrin trafficking and
FAK/Src dependent cell-matrix adhesions in human epithelial
cells.
N.G. Naydenov, A. Feygin and A.I. Ivanov. Virginia
Commonwealth Univ.
9:45
132.6
Resolvin D1 receptor activation counter-
regulates H1 histamine receptors in human and rat conjunctival
goblet cells.
R.R. Hodges, D. Li, R.B. Carozza, J. Jiao, M.A.
Shatos, N. Chiang, C.N. Serhan and D.A. Dartt. Schepens
Eye Res. Inst./Massachusetts Eye and Ear, Harvard Insts. of
Med. and Harvard Med. Sch.
10:00
132.7
g-Cytoplasmic actin modulates epithelial to
myofibroblast transition in lung epithelial cells.
S. Baranwal, P.
Gupta and A.I. Ivanov. Virginia Commonwealth Univ. Sch. of
Med.
10:15
132.8
The N-formyl peptide receptor 1 is required
for enteric commensal mediated mucosal homeostasis and
restitution.
A. Alam, G. Leoni, C. Wentworth, J. Kwal, R.
Jones, C. Ardita, P. Swanson II, A. Nusrat and A. Neish.
Emory Univ. Sch. of Med.
10:30
132.9
Novel role of suppressor of cytokine signaling
3 in regulating LPS-induced matrix metalloproteinase 13 gene
expression in osteoblasts.
A. Gao, A. Kantarci, H. Gao and T.
Van Dyke. The Forsyth Inst. and Brigham and Women’s Hosp.
10:45
132.10 MUC2 exocytosis in intestinal goblet cells. S.
Cornick, F. Moreau and K. Chadee. Univ. of Calgary, Canada.
11:00
132.11 Aortic carboxypeptidase-like protein enhances
lung myofibroblast differentiation.
K.E. Tumelty, B.D. Smith
and M.D. Layne. Boston Univ. Sch. of Med.
133. 13TH ANNUAL CAREER DEVELOPMENT
PROGRAM AND LUNCH: DANCING WITH
JOURNALS: A GUIDE TO MANUSCRIPT
SUBMISSION AND REVIEW
Special Session
(Sponsored by: ASIP Committee for Career
Development, Women & Minorities, American Association
of Anatomists and the FASEB MARC (Maximizing Access
to Research Careers) Program)
s
un
. 11:45
am
—W
estin
B
oston
W
aterFront
h
otel
,
G
ranD
B
allroom
C
C
haired
: D. B
ielenBerG
anD
G. p
erry
Career Development
This session is cosponsored by the ASIP Committee for
Career Development, Women & Minorities and the American
Association of Anatomists. All participants in Experimental
Biology 2013 are invited to attend; however, special registration
is required so we can reserve sufficient seats for this lunch event.
“Dancing with Journals: A Guide to Manuscript Submission and
Review” offers a unique opportunity to gain an insider’s view of
how to get your scientific research published in a peer-reviewed
journal. Editors-in-chief of successful scientific journals will
share their insights into processes of manuscript preparation
(including scientific integrity) and review and editorial decision-
making. Following the editors’ presentations, participants will
have an opportunity to ask questions. There will also be time to
become acquainted with other trainees and junior faculty at other
institutions. Pre-registration is required for this session. Lunch is
provided. You can register for this optional event when you register
for the EB 2013 meeting or can obtain a ticket at the meeting (if
seats are still available) at the EB registration desk.
Dostları ilə paylaş: |